Initiation of our existence in market focusing on cosmetic products for personal care manufactured and distributed by mash pharma
Mash Premiere constructing and licensing a new facility (Biomed For pharmaceutical industries) to cover antibiotic needs from cephalosporin (tablet, capsule, dry powder).
Mash premiere according to IMS is ranked as 25 in the second quarter of 2018 out of 844 from national &international pharmaceutical companies this is just the beginning.
We reach now more than 180 registered and marketed products and more than 240 in our pipeline
Mash premiere with its continuous efforts in treatment of patients and screening for undiagnosed patients fighting epidemic diseases such as HCV has been honored by WHO “World Health Organization” for its unique contribution in curing patients